Cargando…
Benchmarking the ability of novel compounds to inhibit SARS-CoV-2 main protease using steered molecular dynamics simulations
BACKGROUND: The SARS-CoV-2 main protease (M(pro)) is an attractive target in the COVID-19 drug development process. It catalyzes the polyprotein's translation from viral RNA and specifies a particular cleavage site. Due to the absence of identical cleavage specificity in human cell proteases, t...
Autores principales: | Singh, Rahul, Bhardwaj, Vijay Kumar, Das, Pralay, Bhattacherjee, Dhananjay, Zyryanov, Grigory V., Purohit, Rituraj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052739/ https://www.ncbi.nlm.nih.gov/pubmed/35551011 http://dx.doi.org/10.1016/j.compbiomed.2022.105572 |
Ejemplares similares
-
Evaluation of acridinedione analogs as potential SARS-CoV-2 main protease inhibitors and their comparison with repurposed anti-viral drugs
por: Bhardwaj, Vijay Kumar, et al.
Publicado: (2021) -
Mechanochemical Approach towards Multi-Functionalized 1,2,3-Triazoles and Anti-Seizure Drug Rufinamide Analogs Using Copper Beads
por: Bhattacherjee, Dhananjay, et al.
Publicado: (2022) -
A computational approach for rational discovery of inhibitors for non-structural protein 1 of SARS-CoV-2
por: Singh, Rahul, et al.
Publicado: (2021) -
Potential of turmeric-derived compounds against RNA‐dependent RNA polymerase of SARS‐CoV‐2: An in-silico approach
por: Singh, Rahul, et al.
Publicado: (2021) -
Target identification, screening and in vivo evaluation of pyrrolone-fused benzosuberene compounds against human epilepsy using Zebrafish model of pentylenetetrazol-induced seizures
por: Tanwar, Garima, et al.
Publicado: (2019)